000 02633cam a2200289 a 4500
005 20250918150710.0
008 120228s2011 flua b 001 0 eng
020 _a9781439806180
_cRM597.22
039 9 _a201204301102
_bzainol
_y02-28-2012
_zrazalis
040 _aUKM
090 _aWB340.R185d 2011 9
090 _aWB340
_b.R185d 2011 9
100 1 _aRanade, Vasant V.
245 1 0 _aDrug delivery systems /
_cVasant V. Ranade, John B. Cannon.
250 _a3rd ed.
260 _aBoca Raton :
_bCRC Press,
_c2011.
300 _axviii, 590 p. :
_bill. ;
_c25 cm.
520 _a'Drug delivery technologies represent a vast and vital area of research and development in pharmaceutics. The demand for innovative drug delivery systems continues to grow, and this growth drives a variety of new developments. Building on the foundation provided by the second edition, Drug Delivery Systems, Third Edition covers the latest in research, development, and regulations in industry and academia.The third edition of this popular book provides a comprehensive review of the latest research and development on drug delivery systems (including liposomal, transmucosal, transdermal, oral, polymeric, and monoclonal antibody directed delivery); it also contains a new chapter on nanoscience and technology for drug delivery along with cutting-edge business intelligence and strategies. These topics are spread into five sections: Site-specific drug delivery Polymers and implantable drug delivery systems Oral drug delivery Transdermal, transmucosal, ocular, and miscellaneous drug delivery systems Regulatory considerations and global outlook Written in a straightforward, clear, and concise manner, the authors provide a global perspective on current and future advances and market opportunities. The book answers the need for comprehensive information in a single resource for anyone venturing into this area of drug development and who desires an overview of the field, with extensive guidance on where to gain more information. Each chapter provides a table of marketed and investigational products, with numerous practical examples; the book also provides readers with a multitude of possible drug delivery systems that can be used to improve therapeutics, along with global and regulatory perspectives'--Provided by publisher.
650 2 _aDrug delivery systems.
700 1 _aCannon, John B.
907 _a.b15255001
_b2021-05-28
_c2019-11-12
942 _c01
_n0
_kWB340.R185d 2011 9
914 _avtls003489130
991 _aFakulti Farmasi, KKL
998 _ad
_b2012-02-02
_cm
_da
_feng
_gflu
_y0
_z.b15255001
999 _c509575
_d509575